Clinical UpdatesAng-2/VEGF inhibitionFaricimab
Predictive Value of Early Fluid Resolution for Long-term Durability of Faricimab in Neovascular Age-Related Macular Degeneration: A Synthesis of Evidence
By MedXY|Mar 28, 2026
This review synthesizes clinical trial data demonstrating that rapid resolution of retinal fluid by week 12 with faricimab significantly predicts long-term treatment durability in patients with neovascular age-related macular degeneration.